Velocity Clinical Research, Inc.

Velocity Clinical Research, Inc. is a leading integrated site organization specializing in the management and execution of clinical trials. With over 70 research sites across the United States and Europe, the company partners with pharmaceutical and biotechnology firms to advance the development of new drugs, medical devices, diagnostics, and combination products aimed at improving human health and well-being.

Established in 1986, Velocity has conducted more than 15,000 clinical trials, demonstrating a long-standing commitment to advancing medical research. The organization boasts a network of over 200 investigators with diverse expertise, enabling it to offer comprehensive research site solutions.

These solutions efficiently provide the right patients, investigators, and research staff for clinical trials of any scale. In addition to its extensive network, Velocity has been proactive in expanding its capabilities through strategic partnerships and acquisitions.

Recent Initiatives

In January 2025, the company partnered with Verified Clinical Trials to implement advanced participant verification technology across its global sites. This addresses the critical issue of double enrollment in clinical studies.

This initiative enhances patient safety and data integrity, ensuring that participants are not enrolled in multiple studies simultaneously, which could jeopardize their health and compromise research outcomes.

Velocity's commitment to diversity and inclusion is evident in its acquisition of MedPharmics in September 2022. This acquisition added eight sites across five U.S. states, providing access to diverse patient populations, including African American and Native American communities.

This strategic move aims to address the underrepresentation of minority groups in clinical research, ensuring that study results are more reflective of the general population.

Global Locations

The company's global footprint includes locations in multiple U.S. states and European countries. The U.S. states include:

• Alabama
• Arizona
• California
• Colorado
• South Carolina
• Lafayette, LA, USA

European countries where Velocity operates include:

• Germany
• Poland
• United Kingdom

Therapeutic Focus Areas

Velocity conducts clinical trials across a wide range of therapeutic areas, including:

• Cardiometabolic diseases
• Respiratory conditions
• Vaccines
• Women's health

Technology and Innovation

Velocity's dedication to innovation is evident in its technology hub in India, where it develops advanced systems to leverage expansive site, patient, and historical performance data.

This initiative aims to unlock a new era in clinical research by enhancing data analysis capabilities and improving the efficiency of clinical trials.

Summary

In summary, Velocity Clinical Research, Inc. stands at the forefront of clinical trial site organizations, offering a vast network of research sites and a diverse team of investigators.

The company's commitment to innovation, diversity, strategic partnerships, and acquisitions continues to play a pivotal role in advancing medical research and improving patient outcomes worldwide.